Amoxicillin and Clavulanate

Brand names: Augmentin · Active ingredient: Amoxicillin, Clavulanate Potassium

In short: Amoxicillin and clavulanate potassium tablets are indicated for the treatment of lower respiratory tract infection due to confirmed or suspected beta-lactamase producing Haemophilus influenzae and Moraxella catarrhalis as follows : Amoxicillin and Clavulanate Potassium Tablets: adults and pediatric

Forms & strengths250 mg/125 mg : White to off-white, oval shaped, film-coated tablets, debossed with ‘A’ on one side and ‘63’ on the other side, contains 250 mg of amoxicillin USP (as amoxicillin trihydrate) and 125 mg of clavulanic acid as the potassium salt. …
LabelBryant Ranch Prepack
Label updatedNov 16, 2026

What is Amoxicillin and Clavulanate used for?

Amoxicillin and clavulanate potassium tablets are indicated for the treatment of lower respiratory tract infection due to confirmed or suspected beta-lactamase producing Haemophilus influenzae and Moraxella catarrhalis as follows :

Amoxicillin and Clavulanate Potassium Tablets: adults and pediatric patients weighing greater than or equal to 40 kg

Amoxicillin and clavulanate potassium tablets are indicated for the treatment of acute bacterial sinusitis due to confirmed or suspected beta-lactamase-producing Haemophilus influenzae and Moraxella catarrhalis as follows :

Amoxicillin and Clavulanate Potassium Tablets: adults and pediatric patients weighing greater than or equal to 40 kg

Amoxicillin and clavulanate potassium tablets are indicated for the treatment of acute bacterial otitis media due to confirmed or suspected beta-lactamase-producing Haemophilus influenzae and Moraxella catarrhalis as follows :

Amoxicillin and Clavulanate Potassium Tablets: adults and pediatric patients weighing greater than or equal to 40 kg

Amoxicillin and clavulanate potassium tablets are indicated for the treatment of skin and skin structure infections due to confirmed or suspected beta-lactamase-producing S. …

Amoxicillin and Clavulanate dosage

The recommended dosage and administration for the amoxicillin and clavulanate potassium tablets, depends on the indication, patient age, weight, and ability to swallow tablets. Therefore, carefully follow the recommended dosage and administration instructions specified below .

Amoxicillin and clavulanate potassium tablets should only be used in adults and pediatric patients weighing 40 kg or more who can swallow tablets whole [see Indications and Usage (1), Dosage and Administration (2.2), Use in Specific Populations (8.4)].

Pediatric patients weighing 40 kg or more who can swallow tablets should receive the adult dose [see Indications and Usage (1), Dosage and Administration (2.2), Use in Specific Populations (8.4)].

Substitution among amoxicillin and clavulanate potassium formulations should only occur when the amoxicillin-­to-clavulanic acid ratio is matched; AUGMENTIN Chewable Tablets and Oral Suspension are substitutable on a mg-per-mg basis, and certain Amoxicillin and Clavulanate Potassium Tablet strengths are substitutable with specific AUGMENTIN for Oral Suspension or Chewable Tablet strengths. .

The recommended dosage for adults and pediatric patients weighing 40 kg or more who are able to swallow tablets are provided in Table 1.

Amoxicillin and Clavulanate Potassium Tablets

Amoxicillin and clavulanate potassium tablets may be taken without regard to meals; however, absorption of clavulanate is enhanced when amoxicillin and clavulanate potassium tablets are administered at the start of a meal. To minimize the potential for gastrointestinal intolerance, amoxicillin and clavulanate potassium tablets should be taken at the start of a meal.

Table 1. Recommended Dosage for Amoxicillin and Clavulanate Potassium Tablets in Adult and Pediatric Patients Weighing 40 kg or More

Infection Type | Frequency | Dose | Formulation Strength

Amoxicillin and Clavulanate Potassium Tablets

Mild to Moderate Infections | Every 12 hours | One tablet | 500 mg/125 mg

Every 8 hours | One tablet | 250 mg/125 mg

Severe Infections | Every 12 hours | One tablet | 875 mg/125 mg

Every 8 hours | One tablet | 500 mg/125 mg

For patients who are unable to swallow tablets, see Table 6 for guidance on substitution across formulations .

AUGMENTIN ES-600 for Oral Suspension is not a substitute for Amoxicillin and Clavulanate Potassium Tablets in adults.

Amoxicillin and Clavulanate Potassium Tablets should not be used in pediatric patients weighing less than 40 kg due to different amoxicillin-to-clavulanic acid ratios [see Indications and Usage (1), Dosage and Administration (2.8), Use in Specific Populations (8.4)]. …

How to take Amoxicillin and Clavulanate — instructions & advice from the label

Allergic Reactions

Counsel patients that amoxicillin and clavulanate potassium tablets contains a penicillin class drug product that can cause allergic reactions in some individuals .

Severe Cutaneous Adverse Reactions (SCAR)

Advise patients about the signs and symptoms of serious skin manifestations. Instruct patients to stop taking amoxicillin and clavulanate potassium tablets immediately and promptly report the first signs or symptoms of skin rash, mucosal lesions, or any other sign of hypersensitivity .

Diarrhea

Counsel patients that diarrhea is a common problem caused by antibacterial drugs, including Amoxicillin and clavulanate potassium tablets, which usually ends when the antibacterial is discontinued. Sometimes after starting treatment with antibacterial drugs, patients can develop watery and bloody stools (with or without stomach cramps and fever) even as late as 2 or more months after having taken the last dose of the antibacterial drug. If this occurs, patients should contact their physician as soon as possible. If diarrhea develops and is severe or lasts more than 2 or 3 days, advise the patients to call their doctor . …

Warnings & precautions

Do not take this medicine if: Amoxicillin and clavulanate potassium tablets are contraindicated in patients with a history of serious hypersensitivity reactions (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin, clavulanate or to other beta-lactam antibacterial drugs (e.g., penicillins and cephalosporins).

Amoxicillin and clavulanate potassium tablets are contraindicated in patients with a previous history of cholestatic jaundice/hepatic dysfunction associated with treatment with amoxicillin/clavulanate potassium.

Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving beta-lactam antibacterials. These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity and/or a history of sensitivity to multiple allergens. Before initiating therapy with amoxicillin and clavulanate potassium, careful inquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins, or other allergens. Amoxicillin and clavulanate potassium is contraindicated in patients with a history of serious hypersensitivity reactions to amoxicillin, clavulanate, or to other beta-lactam antibacterial drugs . If an allergic reaction occurs, discontinue amoxicillin and clavulanate potassium and institute appropriate therapy.

Amoxicillin and clavulanate potassium may cause severe cutaneous adverse reactions (SCAR), such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP). If patients develop a skin rash, they should be monitored closely, and amoxicillin and clavulanate potassium discontinued if lesions progress. …

Amoxicillin and Clavulanate side effects

The following clinically significant adverse reactions are described elsewhere in the labeling:

Serious Allergic Reactions, including Anaphylaxis

Severe Cutaneous Adverse Reactions

Drug-Induced Enterocolitis Syndrome (DIES)

Hepatic Dysfunction

Clostridioides difficile-associated diarrhea (CDAD)

Skin Rash in Patients with Mononucleosis

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

Amoxicillin and Clavulanate Potassium Tablets

The most frequently reported adverse reactions in clinical trials were diarrhea/loose stools (9%), nausea (3%), skin rash and urticaria (3%), vomiting (1%) and vaginitis (1%). Less than 3% of patients discontinued therapy due to adverse reactions. The overall incidence of adverse reactions, particularly diarrhea, increased with higher recommended doses. Other less frequently reported adverse reactions (<1%) included abdominal discomfort, flatulence, and headache.

In two pivotal trials in adults with lower respiratory tract or urinary tract infections, the overall incidence of adverse reactions was similar between amoxicillin and clavulanate potassium 875 mg/125 mg tablets every 12 hours and amoxicillin and clavulanate potassium 500 mg/125 mg tablets every 8 hours . …

Drug interactions

Probenecid decreases the renal tubular secretion of amoxicillin. Concurrent use with amoxicillin and clavulanate potassium may result in increased and prolonged blood levels of amoxicillin. Co-administration of probenecid is not recommended.

Abnormal prolongation of prothrombin time (increased international normalized ratio [INR]) has been reported in patients receiving amoxicillin and oral anticoagulants. Appropriate monitoring should be undertaken when anticoagulants are prescribed concurrently. Adjustments in the dose of oral anticoagulants may be necessary to maintain the desired level of anticoagulation.

The concurrent administration of allopurinol and amoxicillin increases substantially the incidence of rashes in patients receiving both drugs as compared to patients receiving amoxicillin alone. It is not known whether this potentiation of amoxicillin rashes is due to allopurinol or the hyperuricemia present in these patients. Discontinue allopurinol at the first appearance of skin rash when used concomitantly with amoxicillin and clavulanate potassium.

High urine concentrations of amoxicillin may result in false-positive reactions when testing for the presence of glucose in urine using CLINITEST®, Benedict’s Solution, or Fehling’s Solution. …

About this medicine

Amoxicillin and clavulanate potassium tablets, USP are an oral antibacterial combination consisting of the semisynthetic antibacterial amoxicillin and the beta-lactamase inhibitor clavulanate potassium (the potassium salt of clavulanic acid).

In Amoxicillin and clavulanate potassium tablets USP, amoxicillin is present as amoxicillin trihydrate.

Amoxicillin USP is an analog of ampicillin, derived from the basic penicillin nucleus, 6-aminopenicillanic acid.

Amoxicillin trihydrate has a molecular formula of C16H19N3O5S•3H2O and a molecular weight of 419.46. Chemically, it is (2S,5R,6R)-6-[(R)-(-)-2-Amino-2-(p-hydroxyphenyl)acetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo [3.2.0] heptane-2-carboxylic acid trihydrate and may be represented structurally as:

Clavulanic acid is produced by the fermentation of Streptomyces clavuligerus. It is a beta-lactam structurally related to the penicillins and possesses the ability to inactivate a wide variety of beta-lactamases by blocking the active sites of these enzymes. …

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 80be54ec-2a38-4125-a1a8-e58f50800dd2. Read the full official label on DailyMed.

Related medicines

Amoxicillin Azithromycin Doxycycline Cephalexin Valacyclovir Sulfamethoxazole and Trimethoprim Nitrofurantoin Clindamycin